Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Category: digital therapeutics

FDA approves Click’s digital therapeutic for episodic migraine

FDA approves Click’s digital therapeutic for episodic migraine
p p Read More

More than 37 million adults in the US are affected by migraine

April 17, 2025 Click Therapeutics, CT-132, digital therapeutics, FDA, News
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy